Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 1
1948 2
1949 1
1951 3
1953 1
1954 1
1955 4
1956 2
1957 11
1958 11
1959 7
1960 10
1961 6
1962 9
1963 12
1964 13
1965 10
1966 3
1967 5
1968 9
1969 11
1970 8
1971 13
1972 11
1973 18
1974 21
1975 15
1976 9
1977 25
1978 19
1979 17
1980 23
1981 15
1982 11
1983 18
1984 16
1985 12
1986 17
1987 21
1988 17
1989 14
1990 14
1991 14
1992 17
1993 14
1994 18
1995 25
1996 23
1997 24
1998 37
1999 45
2000 35
2001 48
2002 43
2003 43
2004 49
2005 39
2006 33
2007 35
2008 28
2009 34
2010 28
2011 30
2012 30
2013 39
2014 51
2015 50
2016 45
2017 37
2018 33
2019 31
2020 32
2021 43
2022 28
2023 30
2024 29
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,526 results

Results by year

Filters applied: . Clear all
Page 1
Power posing: brief nonverbal displays affect neuroendocrine levels and risk tolerance.
Carney DR, Cuddy AJ, Yap AJ. Carney DR, et al. Psychol Sci. 2010 Oct;21(10):1363-8. doi: 10.1177/0956797610383437. Epub 2010 Sep 20. Psychol Sci. 2010. PMID: 20855902
The results of this study confirmed our prediction that posing in high-power nonverbal displays (as opposed to low-power nonverbal displays) would cause neuroendocrine and behavioral changes for both male and female participants: High-power posers experienced elevations in …
The results of this study confirmed our prediction that posing in high-power nonverbal displays (as opposed to low-power nonverbal displays) …
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis.
Zipoli V, Portaccio E, Siracusa G, Pracucci G, Sorbi S, Amato MP. Zipoli V, et al. Mult Scler. 2003 Oct;9(5):481-5. doi: 10.1191/1352458503ms956oa. Mult Scler. 2003. PMID: 14582774
Four neurologists were asked to make a diagnosis using Poser's and McDonald's criteria and to assess MRI scans according to the McDonald's guidelines. ...The new McDonald's criteria yield a good overall diagnostic reliability, and compare favourably with Poser …
Four neurologists were asked to make a diagnosis using Poser's and McDonald's criteria and to assess MRI scans according to th …
Pseudo-tumoral multiple sclerosis.
Poser CM. Poser CM. Clin Neurol Neurosurg. 2005 Oct;107(6):535. doi: 10.1016/j.clineuro.2005.04.007. Epub 2005 May 31. Clin Neurol Neurosurg. 2005. PMID: 15925441 No abstract available.
Training behavior therapists.
Poser EG. Poser EG. Behav Res Ther. 1967 Feb;5(1):37-41. doi: 10.1016/0005-7967(67)90053-8. Behav Res Ther. 1967. PMID: 4166967 No abstract available.
Schilder's disease: non-invasive diagnosis? :A case report and review.
Bacigaluppi S, Polonara G, Zavanone ML, Campanella R, Branca V, Gaini SM, Tredici G, Costa A. Bacigaluppi S, et al. Neurol Sci. 2009 Oct;30(5):421-30. doi: 10.1007/s10072-009-0113-z. Epub 2009 Jul 17. Neurol Sci. 2009. PMID: 19609739 Review.
Clinical signs and symptoms might be atypical for early multiple sclerosis and at imaging the lesion is easily taken for a brain tumour. Regardless of the use of Poser's criteria for clinical diagnosis of Schilder's disease proposed in 1986, diagnostic difficulties …
Clinical signs and symptoms might be atypical for early multiple sclerosis and at imaging the lesion is easily taken for a brain tumour. Reg …
Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria.
Fangerau T, Schimrigk S, Haupts M, Kaeder M, Ahle G, Brune N, Klinkenberg K, Kotterba S, Möhring M, Sindern E; Multiple Sclerosis Study Group. Fangerau T, et al. Acta Neurol Scand. 2004 Jun;109(6):385-9. doi: 10.1111/j.1600-0404.2004.00246.x. Acta Neurol Scand. 2004. PMID: 15147460
Conversely, 75% of the 39 patients, who fulfilled the new McDonald criteria for MS were assigned to the category of clinically definite MS according to the Poser criteria, and 83% of the patients with a 'possible MS' using the McDonald criteria, had a laboratory definite M …
Conversely, 75% of the 39 patients, who fulfilled the new McDonald criteria for MS were assigned to the category of clinically definite MS a …
The STAT3-Ser/Hes3 signaling axis in cancer.
Poser SW, Park DM, Androutsellis-Theotokis A. Poser SW, et al. Front Biosci (Landmark Ed). 2014 Jan 1;19(4):718-26. doi: 10.2741/4238. Front Biosci (Landmark Ed). 2014. PMID: 24389215 Free article. Review.
Charles Marcel Poser, MD, FAAN (1923-2010).
Román GC. Román GC. Neurology. 2011 Apr 26;76(17):1454-5. doi: 10.1212/wnl.0b013e318217e7f1. Neurology. 2011. PMID: 21671535 No abstract available.
Postvaccinal encephalitis.
Poser CM. Poser CM. Ann Neurol. 1983 Mar;13(3):341-2. doi: 10.1002/ana.410130322. Ann Neurol. 1983. PMID: 6133498 No abstract available.
Disseminated vasculomyelinopathy.
Poser CM. Poser CM. Ann Neurol. 1980 Nov;8(5):550. doi: 10.1002/ana.410080517. Ann Neurol. 1980. PMID: 7436400 No abstract available.
1,526 results